Table 1 Sample characterization of 736 intravitreal injections (IVIs)
N (%) | |
|---|---|
Drug injected | |
Bevacizumab | 113 (15.4%) |
Aflibercept | 623 (84.6%) |
Indications for IVI | |
Age-related macular degeneration | 469 (63.7%) |
Retinal venous occlusion | 193 (26.2%) |
Diabetic macular edema | 55 (7.5%) |
Telangiectasia | 5 (0.7%) |
Myopic choroidal neovascular membrane | 2 (0.3%) |
Proliferative retinopathy due to central arterial retinal occlusion | 2 (0.3%) |
Other | 10 (1.4%) |